With the clock ticking, scientists working with human embryonic stem cells were grappling Tuesday with how to use their remaining federal research funds before a court ruling forces them to bring their work to an abrupt end.
Recent Posts
- AI Helps Identify Regulatory Hub for Aging in Hematopoietic Stem Cells
- First-in-human pilot trial improves stem cell collection and delivery for sickle cell gene therapy
- Scientists Supercharge Natural Killer Cells To Attack Solid Tumors
- Pluripotency, differentiation, and reprogramming: 20 years of induced pluripotent stem cells
- Hydrogel platform uses vitamin B2 and blue light to simplify living tissue models
- 3D-printed spheroids enable dual bone and vascular tissue development
